Ethic Inc’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Buy
5,585
+213
+4% +$23.2K 0.01% 769
2026
Q1
$496K Buy
5,372
+14
+0.3% +$1.41K 0.01% 872
2025
Q4
$547K Buy
5,358
+1,503
+39% +$134K 0.01% 823
2025
Q3
$241K Sell
3,855
-406
-10% -$22.1K ﹤0.01% 1047
2025
Q2
$217K Buy
+4,261
New +$190K ﹤0.01% 1091

Other funds holding GH

Ethic Inc's GH Position: Q2 2026 in Review

Ethic Inc increased its Guardant Health (GH) stake by 4% in Q2 2026, buying an estimated $23.2K and bringing the position to 5,585 shares worth $838K. The position accounts for 0.01% of the portfolio, ranked #769.

Ethic Inc first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Ethic Inc held 5,585 shares of Guardant Health worth $838K as of Q2 2026.
  • Ethic Inc bought 213 Guardant Health shares in Q2 2026, an estimated $23.2K.
  • Guardant Health made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #769 holding.
  • Ethic Inc first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.